ストックスクリーナーアプリを入手
1.23
0.82%
0.01
プレマーケット:
1.24
0.01
+0.81%
Heron Therapeutics Inc (HRTX) 最新ニュース
Heron Therapeutics (HRTX) COO gains 11,770 shares through RSU conversion - Stock Titan
Heron EVP exercises RSUs into 23,464 common shares | HRTX Insider Trading - Stock Titan
[Form 4] HERON THERAPEUTICS, INC. /DE/ Insider Trading Activity - Stock Titan
Heron Therapeutics (NASDAQ: HRTX) CEO converts 84,810 RSUs to shares - Stock Titan
Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
[ARS] HERON THERAPEUTICS, INC. /DE/ SEC Filing - Stock Titan
Heron Therapeutics (NASDAQ: HRTX) seeks approval for major new equity pools - Stock Titan
Heron Therapeutics (NASDAQ:HRTX) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
Heron Therapeutics (HRTX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 - Sahm
Heron sets May 11 webcast for Q1 results and business updates - Stock Titan
Heron Therapeutics outlines $173M–$183M 2026 sales targets amid acute care momentum and expanded commercial investment - MSN
Research Analysts Set Expectations for HRTX Q1 Earnings - MarketBeat
HRTX Edges Higher As Insider Ownership Change Draws Attention - StocksToTrade
Heron Therapeutics files $125M mixed securities shelf - MSN
H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $6 - Moomoo
HC Wainwright Cuts Earnings Estimates for Heron Therapeutics - MarketBeat
Heron CEO exercises 13,797 RSUs into shares | HRTX Insider Trading - Stock Titan
Heron Therapeutics (NASDAQ: HRTX) seeks shareholder approval to add 26.56M shares across incentive plans - Stock Titan
Heron Therapeutics (HRTX) Stock: Final Thoughts (-1.75%) 2026-04-16Low Volatility Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Heron Therapeutics, Inc. (HRTX) Stock Analysis: A Promising 352.95% Potential Upside Worth Exploring - DirectorsTalk Interviews
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $3 - Moomoo
EBITDA per share of Heron Therapeutics Inc – LSE:0J4V - TradingView — Track All Markets
Total debt per share of Heron Therapeutics Inc – LSE:0J4V - TradingView — Track All Markets
Pullback Watch: Can Heron Therapeutics Inc expand into new markets2026 Sector Moves & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
What scenarios affect Heron Therapeutics (HRTX) Stock price | Price at $0.81, Up 3.09%Buy Opportunities - Cổng thông tin điện tử tỉnh Tây Ninh
Heron Therapeutics (HRTX) CEO exercises 62,500 RSUs into common stock - Stock Titan
Earnings Miss: How does Heron Therapeutics Inc compare to its peersQuarterly Trade Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Heron Therapeutics Executive Employment Agreements: Key Terms, Termination, and Restrictive Covenants Explained - Minichart
Heron Therapeutics Strengthens Executive Contracts Amid Strategic Focus - TipRanks
Heron Therapeutics (NASDAQ: HRTX) revises executive severance and CIC - Stock Titan
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Analysts - marketbeat.com
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of “Hold” by Analysts - Defense World
HRTX Stock Analysis: Heron Therapeutics Inc. Biotech Stock at $0.8 After Minor Daily Dip - Cổng thông tin điện tử tỉnh Lào Cai
HRTX Stock Price, Quote & Chart | HERON THERAPEUTICS INC (NASDAQ:HRTX) - ChartMill
Q1 Earnings Forecast for HRTX Issued By Northland Securities - MarketBeat
Moving Averages: How does Heron Therapeutics Inc compare to its peersWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Wall Street Recap: How does Heron Therapeutics Inc compare to its peersTrade Entry Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Vanguard realigns holdings; Heron Therapeutics (HRTX) ownership shown as 0 - Stock Titan
What is Northland Securities' Estimate for HRTX Q3 Earnings? - MarketBeat
If You Invested $1,000 in Heron Therapeutics Inc (HRTX) - Stock Titan
Heron Therapeutics, Inc. (HRTX) Investor Outlook: A 415% Upside Potential In Biotechnology - DirectorsTalk Interviews
Market Trends: Is Heron Therapeutics Inc stock technically oversold2026 Key Highlights & Daily Momentum Trading Reports - baoquankhu1.vn
Clearline Capital LP Increases Holdings in Heron Therapeutics, Inc. $HRTX - MarketBeat
Baker BROS. Advisors LP Purchases New Position in Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a Promising 346% Potential Upside - DirectorsTalk Interviews
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
HRTX SEC FilingsHeron Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Citigroup Inc. Increases Stock Position in Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics Signals Profitable Growth After Strong Quarter - TipRanks
Earnings Call Summary | Heron Therapeutics(HRTX.US) Q4 2025 Earnings Conference - 富途牛牛
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):